Form D · Pharmaceuticals
ChoroPharma, LLC
Raleigh, NC · CIK 0001913116
Offering snapshot reported Feb 23, 2022 · SEC filing
- Reported sold
- $90K Offering amount: $150K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Feb 2, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 23, 2022 | Initial | $90,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-434694
Source: Form D, filed Feb 23, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kristian Troy Chavis | Director, Executive |
| Paulina Valsecchi Chavis | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1630 Medlin Creek Loop Unit 301
Raleigh, NC, 27607
Raleigh, NC, 27607